Pentraxin Therapeutics Ltd.

GlaxoSmithKline PLC , is boosting its research efforts into rare and orphan diseases by entering into a collaboration with the Canadian company Angiochem Inc. In exchange for up to $300 million, i

Pfizer's ambitious tie-ups with multiple research institutions across several cities is but the latest model of academic-industry collaboration, highlighting pharma's ongoing hunger for fresh approach

The biopharmaceutical industry's perennial search for innovation continues to drive diverse alliance activity between commercial partners of all stripes. More recently, the macroeconomic climate has b